Transjugular Intrahepatic Portosystemic Shunt with the Strecker Stent for Control of Refractory Acute and Chronic Variceal Bleeding Results in 50 Patients

References

• Bosch J, Pizcueta P, Feu F, Fernandez M, García-Pagán JC. Pathophysiology of portal hypertension. Gastroenterology Clin North Am 1992; 21: 1–14
   PubMed Web of Science ®Google Scholar
• Bosch J, García-Pagán JC, Feu F, Pizcueta P MP. Portal hypertension. Hepatobiliary diseases, J Prieto, J Rodés, D Schafritz. Springer-Verlag, Heidelberg 1992; 429–64
   Google Scholar
• Borroughs AK, Bosch J. Clinical manifestation and management of bleeding episodes in cirrhotics. Oxford textbook of clinical hepatology, M McIntyre, JP Benhamou, J Bircher, M Ritzeto, J Rodés. Oxford University Press, Oxford 1991
   Google Scholar
• Terés J, Bórdas JM, Bosch J. Hemorragia digestiva. Editorial Doyma, Barcelona 1991
   Google Scholar
• García-Pagán JC, Téres J, Calvet X, Bosch J, Rodés J. Factors which influence the prognosis of the first episode of variceal hemorrhage in patients with cirrhosis. Recent advances in the pathophysiology and therapy in portal hypertension, Bosch J, J Rodés. Serono Symp Rev. 1989; 287–32
   Google Scholar
• Bosch J, Terés J. Immediate management of variceal hemorrhage. Pharmacologic measures and balloon tamponade. Gastrointest Endoscop Clin North Am 1992; 2: 43–58
   Google Scholar
• Planas R, Boix J, Broggi M, Cabré E, Gomez-Vieira MC, Morillas R. Portacaval shunt versus endoscopic sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1991; 100: 1078–86
   PubMed Web of Science ®Google Scholar
• Bosch J. Treatment of acute variceal hemorrhage in patients with cirrhosis. Therapy in liver diseases, J Rodés, V Arroyo. Ediciones Doyma, Barcelona 1991; 89–101
   Google Scholar
• Poynard T, Cales E, Pasta L, Ideo G, Pascal JP, Pagliaro L. Beta-adrenergic in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices: an analysis of data or prognostic factors in 589 patients from four randomized trials. N Engl J Med 1991; 324: 1532–8
   PubMed Web of Science ®Google Scholar
• Pagliaro M, D'Amico G, Sörensen TIA, Lebrec D, Borroughs AK, Morabito A. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of non-surgical treatment. Ann Intern Med 1992; 117: 59–70
   PubMed Web of Science ®Google Scholar
• Teres J, Baromi R, Bordás JM, Visa J, Pera C, Rodés J. Randomized trial of portacaval shunt stapling transection and endoscopic in uncontrolled variceal bleeding. J Hepatol 1987; 4: 159–67
   PubMed Web of Science ®Google Scholar
• Rösch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 1969; 92: 1112–4
   PubMedGoogle Scholar
• Rösch J, Hanafee W, Snow H, Barenfus M, Gray R. Transjugular intrahepatic portacaval shunt: an experimental work. Am J Surg 1971; 121: 588–92
   PubMed Web of Science ®Google Scholar
• Gutierrez OH, Burgener FA. Production of non-surgical portosystemic venous shunts in dogs by transjugular approach. Radiology 1979; 130: 507–9
   PubMedGoogle Scholar
• Rösch J, Uchida BT, Putnam JS, Buschman RW, Law RD, Hershey AL. Experimental intrahepatic portacaval anastomosis: Use of expandable Gianturco stents. Radiology 1987; 162: 481–5
   PubMedGoogle Scholar
• Palmaz JC, Sibbit RR, Reuter SR, Garcia F, Tio FO. Expandable intrahepatic portacaval shunt stents: Early experience in the dog. AJR 1985; 145: 821–5
   PubMedGoogle Scholar
• Palmaz JC, Garcia F, Sibbitt RR, Tio FO, Kopp DT, Schwesinger W. Expandable intrahepatic portacaval shunt stents in dogs with chronic portal hypertension. AJR 1986; 147: 1251–4
   PubMedGoogle Scholar
• Cwikiel W, Stridbeck H. Experimental transjugular portacaval shunt: use of a fine-needle puncture device for the implantation of Strecker stents. Acta Radiol 1992; 33: 356–9
   PubMedGoogle Scholar
• Colapinto RF, Stronell RD, Birch SJ, Gildiner M, Ritchie AC, Langer B. Creation of an intrahepatic portosystemic shunt with a Grüntzig balloon catheter. Can Med Assoc J 1982; 126: 267–8
   PubMedGoogle Scholar
• Richter GM, Noeldge G, Palmaz JC, Roessle M, Slegerstteter V, Franke M. Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology 1990; 174: 1027–30
   PubMedGoogle Scholar
• Richter GM, Noeldge G, Palmaz JC, Roessle M. The transjugular intrahepatic portosystemic stent-shunt (TIPSS): results of a pilot study. Cardiovasc Intervent Radiol 1990; 13: 200–7
   PubMed Web of Science ®Google Scholar
• Zemel G, Katzen BT, Becker GJ, Benenati JF, Sallee DS. Percutaneous transjugular portosystemic shunt. JAMA 1991; 266: 390–3
   PubMed Web of Science ®Google Scholar
• Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med 1992; 116: 304–9
   PubMed Web of Science ®Google Scholar
• La Berge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA. Creation of transjugular intrahepatic portosystemic shunts with the Wallstent endoprosthesis: results in 100 patients. Radiology 1993; 187: 413–20
   PubMedGoogle Scholar
• Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165–71
   PubMed Web of Science ®Google Scholar
• Echenagusia AJ, Camuñez F, Simó G, Peiró J, Garay MG, Rodríguez-Laiz JM. Variceal hemorrhage: efficacy of transjugular intrahepatic portosystemic shunts created with Strecker stents. Radiology 1994; 192: 235–40
   PubMedGoogle Scholar
• Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961; 21: 43–57
   PubMed Web of Science ®Google Scholar
• Conn HO. The trailmaking and number connection tests in the assessment of mental state in portalsystemic encephalopathy. Am J Dig Dis 1977; 4: 150
   Google Scholar
• Jones EA, Schaffer DF. Hepatic encephalopathy. Hepatology: a text book of liver disease, D Zakim, TD Boyer. Saunders, Philadelphia 1990; 450
   Google Scholar
• Conn HO, Grace ND, Bosch J. Propranolol in the prevention of the first hemorrhage from esophageal varices: a multicenter randomized clinical trial. Hepatology 1991; 13: 902–12
   PubMedGoogle Scholar
• Conn HO. Transjugular intrahepatic potal-systemic shunt: the state of the art. Hepatology 1993; 17: 148–58
   PubMed Web of Science ®Google Scholar
• Longo JM, Bilbao JI, Rousseasu HP, García-Villareal L, Vinel JP, Zozaya JM. Transjugular intrahepatic portosystemic shunt: evaluation with Doppler sonography. Radiology 1993; 186: 529–34
   PubMedGoogle Scholar
• Haag K, Sellinger M, Ochs A, Noeldge G, Gerok W, Rossle M. The transjugular intrahepatic portosystemic shunt: factors influencing shunt patency [abstract]. Hepatology 1992; 16: S9–10, Suppl
   Google Scholar
• Rodríguez-Laiz JM, Bańres R, Casado M, Jaime B, Salcedo M, Camuñez F. Incidence and predictive factors of shunt dysfunction after transjugular intrahepatic portosystemic shunts (tips) with the strecker stent [abstract]. Hepatology 1993; 18, Suppl:285A
   Google Scholar
• Henderson JM, Millikan WJ, Warren WD. The distal splenorenal shunt: an update. World J Surg 1984; 8: 722–32
   PubMedGoogle Scholar
• Spina GP, Galeotti F, Opocher E, Santambrogio R, Cuchiaro G, Lopez C. Selective distal splenorenal shunt versus side to side portacaval shunt: clinical results of a prospective controlled study. Am J Surg 1988; 155: 564–71
   PubMedGoogle Scholar
• Reynolds TB, Donovan AJ, Mikkelsen WP, Redeker AG, Turrill FL, Weiner JM. Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices. Gastroenterology 1981; 80: 1005–11
   PubMed Web of Science ®Google Scholar
• Cello JP, Grendell JH, Crass RA, Weber TE, Trunkey DD. Endoscopic sclerotherapy versus portocaval shunt in patients with severe cirrhosis and acute variceal hemorrhage. N Engl J Med 1987; 316: 11–5
   PubMed Web of Science ®Google Scholar
• Gusberg RJ. Distal splenorenal shunt,—premise, perspective, practice. Dig Dis 1992; 10: 84–93
   PubMedGoogle Scholar
• Teres J, Bordas JM, Bravo D, Visa J, Grande L, Garcia-Valdecasas JC. Sclerotherapy vs distal splenorenal shunt in the elective treatment of variceal hemorrhage: a randomized controlled trial. Hepatology 1987; 7: 430–6
   PubMed Web of Science ®Google Scholar
• Grace ND, Conn HO, Resnick RH, Groszman RJ, Atterbury CE, Wright SC. Distal spelenorenal vs portalsystemic shunts after hemorrhage from varices: a randomized controlled trial. Hepatology 1988; 8: 1475–81
   PubMed Web of Science ®Google Scholar
• Harley HAJ, Morgan T, Redeker AG, Reynolds TB, Villamil F, Weiner JM. Results of a randomized trial of end-to-side portocaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology 1986; 91: 802–9
   PubMed Web of Science ®Google Scholar
• Spina GP, Santambrogio R, Opocher E, Consentino F, Zambelli A, Passoni GR. Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding: first stage of a randomized controlled trial. Ann Surg 1990; 211: 178–86
   PubMed Web of Science ®Google Scholar
• Stiegmann GV, Goff JS, Michaeltz-Onody PA, Korula J, Lieberman D, Saeed ZA. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992; 326: 1527–32
   PubMed Web of Science ®Google Scholar
• Terblanche J, Kahn D, Borman PC. Long-term injection sclerotherapy treatment for esophageal varices: a 10-years prospective evaluation. Ann Surg 1989; 210: 725–31
   PubMedGoogle Scholar
• Ink O, Martin T, Poynard T, Reville M, Anciaux ML, Lenoir C. Does elective sclerotherapy improve the efficacy of longterm propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? Prospective, multicenter, randomized trial. Hepatology 1992; 16: 912–9
   PubMedGoogle Scholar
• Westaby D, Polson RJ, Gimson AES, Hayes PC, Hayllar K, Williams R. A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding. Hepatology 1990; 11: 353–9
   PubMed Web of Science ®Google Scholar
• Fleig WE, Stange EF, Hunecke R, Schoönborn W, Hurler U, Rainer K. Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: a prospective randomized comparison of propranolol and sclerotherapy. Hepatology 1987; 7: 355–61
   PubMed Web of Science ®Google Scholar
• Rossi V, Cales P, Burtin P, Charneau J, Person P, Pujol P. Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy. J Hepatol 1991; 12: 283–9
   PubMedGoogle Scholar
• The Italian Multicenter Project for propranolol in prevention of bleeding. Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: a multicenter randomized trial. Hepatology 1988; 8: 1
   PubMed Web of Science ®Google Scholar
• Téres J, Bosch J, Bordás JM, García-Pagan JC, Feu F, Cirera I. Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial. Gastroenterology 1993; 105: 1508–14
   PubMedGoogle Scholar
• Sanyal AJ, Freedman AM, Schiffman ML, Luketic VA, Purdum PP, Tisnado J. Interim report of a prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt (TIPS) versus sclerotherapy for prevention of recurrent variceal hemorrhage. Gut 1993; 34: S6
   Google Scholar
• Rikkers LF, Sorrell WT, Jin G. Which portosystemic shunt is best. Gastroenterol Clin North Am 1992; 21: 179–96
   PubMed Web of Science ®Google Scholar
• Krom RA, Wiesner RH, Rettke SR, Ludwig J, Southorn PA, Hermans PE. The first 100 liver transplantations at the Mayo Clinic. Mayo Clin Proc 1989; 64: 84–94
   PubMed Web of Science ®Google Scholar
• Iwatsuki S, Starlz TE, Todo S, Gordon RE, Tzakis ATG, Marsh JW. Liver transplantation in the treatment of bleeding esophageal varices. Surgery 1988; 104: 697–705
   PubMed Web of Science ®Google Scholar